Regulatory framework
In the Netherlands, the Stichting Transparantieregister Zorg handles the disclosure of financial healthcare relations.
The obligation is rooted in two specific conduct codes:
- For the pharmaceutical sector: Code for Pharmaceutical Advertising (CGR).
- For medical technologies: Code for Medical Devices (GMH).
Who is subject to disclosure?
- Healthcare Professionals (HCPs)
- Healthcare Organizations/institutions (HCOs)
- Patient Organizations (POs)
What information is published?
In the Netherlands, financial relationships are registered based on the following specific agreement types derived from the Foundation Transparency Register Healthcare (Stichting Transparantieregister Zorg):
- Service fee (Honorarium): The fee paid to a healthcare professional or healthcare organization for services rendered, for example consultancy activities, participation in advisory boards, or speaking engagements.
- Service expenses: Expenses reimbursed within the context of a service agreement (as mentioned above), such as travel or accommodation costs. These are listed separately from the honorarium.
- Sponsorship of a meeting: Sponsorship of a meeting or scientific congress where the organizer is a healthcare organization (HCO) or a collaboration of healthcare professionals (for example a scientific association).
- Sponsorship of a project: Sponsorship of a healthcare organization (HCO) or patient organization (PO) for the execution of a project aimed at improving patient care, advancing medical science, supporting medical research, or otherwise promoting education and/or information.
- Hospitality compensation: Compensation (in cash or in kind) of travel, accommodation, and registration costs for individual healthcare professionals to attend a scientific meeting or congress.
Furthermore, Transfers of Value (TOVs) regarding Research & Development (R&D) are also disclosed. We publish these figures directly on this page as they are not part of the central registry.
Publication & retention period
- Annual disclosure takes place around mid-July, covering the preceding calendar year.
- Information remains publicly viewable for 3 years via https://zoeken.transparantieregister.nl/
- R&D data is also maintained and kept accessible on our website for this same three-year period.
Frameworks and references
- CGR — Code for Pharmaceutical Advertising
- GMH — Code for Medical Devices
